• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童使用艾考糊精的临床经验:超滤情况及代谢

Clinical experience with icodextrin in children: ultrafiltration profiles and metabolism.

作者信息

de Boer A W, Schröder C H, van Vliet R, Willems J L, Monnens L A

机构信息

Department of Pediatrics, University Hospital Nijmegen, The Netherlands.

出版信息

Pediatr Nephrol. 2000 Nov;15(1-2):21-4. doi: 10.1007/s004670000406.

DOI:10.1007/s004670000406
PMID:11095005
Abstract

Icodextrin use in adults provides sustained ultrafiltration (UF) in long-term dwells. No information is available on UF and metabolism in children. In 11 children, a volume of 1,049+/-138 ml/m2 of the study fluid (1.36% glucose, 7.5% icodextrin, 3.86% glucose) was administered for 12 h. Net UF with icodextrin (339+/-147 ml/1.73 m2) did not differ from UF with 3.86% glucose (450+/-306 ml/1.73 m2, P=0.53) and was higher than UF with 1.36% glucose (-87+/-239 ml/1.73 m2, P=0.003). Icodextrin added 0.52+/-0.07 to the weekly Kt/V. Over 6 weeks, icodextrin was used for 12-h daytime dwell. Total icodextrin reached a steady-state level of 2.91+/-1.22 g/l at 2 weeks. The main icodextrin metabolites were maltose, maltotriose, and maltotetraose. After 2 weeks, steady state levels were 2.02+/-0.66 mmol/l, 1.46+/-0.35 mmol/l, and 0.45+/-0.12 mmol/l. No icodextrin or metabolites were detectable 4 weeks after the study. We conclude that 7.5% icodextrin is capable of maintaining UF during 12-h dwell in children and is comparable to UF obtained with 3.86% glucose. Steady-state levels of icodextrin and metabolites were reached at 2 weeks and disappeared after the study.

摘要

成人使用艾考糊精在长期留腹时可提供持续超滤。目前尚无关于儿童超滤及代谢情况的信息。在11名儿童中,给予每平方米体表面积1,049±138毫升的研究液(1.36%葡萄糖、7.5%艾考糊精、3.86%葡萄糖),持续12小时。使用艾考糊精时的净超滤量(339±147毫升/1.73平方米)与使用3.86%葡萄糖时的超滤量(450±306毫升/1.73平方米,P = 0.53)无差异,且高于使用1.36%葡萄糖时的超滤量(-87±239毫升/1.73平方米,P = 0.003)。艾考糊精使每周的Kt/V增加0.52±0.07。在6周时间里,艾考糊精用于白天12小时留腹。2周时艾考糊精总量达到稳态水平2.91±1.22克/升。艾考糊精的主要代谢产物为麦芽糖、麦芽三糖和麦芽四糖。2周后,稳态水平分别为2.02±0.66毫摩尔/升、1.46±0.35毫摩尔/升和0.45±0.12毫摩尔/升。研究结束4周后未检测到艾考糊精或其代谢产物。我们得出结论,7.5%艾考糊精能够在儿童12小时留腹期间维持超滤,且与3.86%葡萄糖获得的超滤效果相当。艾考糊精及其代谢产物在2周时达到稳态水平,研究结束后消失。

相似文献

1
Clinical experience with icodextrin in children: ultrafiltration profiles and metabolism.儿童使用艾考糊精的临床经验:超滤情况及代谢
Pediatr Nephrol. 2000 Nov;15(1-2):21-4. doi: 10.1007/s004670000406.
2
Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.日本患者使用7.5%艾考糊精溶液透析期间的腹膜超滤及血清艾考糊精浓度
Perit Dial Int. 2003 Jul-Aug;23(4):356-61.
3
Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.优化、个体化日间单次留腹时间以提高钠和液体清除率的自动化腹膜透析处方:预测分析。
Perit Dial Int. 2013 Nov-Dec;33(6):646-54. doi: 10.3747/pdi.2012.00261.
4
Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.艾考糊精在自动化腹膜透析中的有效性、安全性及生物相容性评估。阿姆斯特丹自动化腹膜透析中的糊精(DIANA)研究组。
Perit Dial Int. 2000;20 Suppl 2:S106-13.
5
Icodextrin: a review of its use in peritoneal dialysis.艾考糊精:其在腹膜透析中应用的综述
Drugs. 2003;63(19):2079-105. doi: 10.2165/00003495-200363190-00011.
6
Three-pore model predictions of 24-hour automated peritoneal dialysis therapy using bimodal solutions.三孔模型预测使用双模态溶液的 24 小时自动化腹膜透析治疗。
Perit Dial Int. 2011 Sep-Oct;31(5):537-44. doi: 10.3747/pdi.2010.00169. Epub 2011 May 31.
7
Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance.在持续循环腹膜透析(CCPD)日间留腹期间使用艾考糊精代替葡萄糖可增加超滤量及24小时透析液肌酐清除率。
Nephrol Dial Transplant. 1997 Mar;12(3):550-3. doi: 10.1093/ndt/12.3.550.
8
The variability in ultrafiltration achieved with icodextrin, possibly explained.使用艾考糊精实现的超滤变异性,可能已得到解释。
Perit Dial Int. 2009 Jul-Aug;29(4):415-21.
9
Impact of fill volume on ultrafiltration with icodextrin in children on chronic peritoneal dialysis.填充量对接受慢性腹膜透析的儿童使用艾考糊精进行超滤的影响。
Pediatr Nephrol. 2016 Oct;31(10):1673-9. doi: 10.1007/s00467-016-3398-1. Epub 2016 May 13.
10
Pharmacokinetics of icodextrin in peritoneal dialysis patients.艾考糊精在腹膜透析患者中的药代动力学
Kidney Int Suppl. 2002 Oct(81):S23-33. doi: 10.1046/j.1523-1755.62.s81.5.x.

引用本文的文献

1
Factors related to ultrafiltration volume with icodextrin dialysate use in children.与使用艾考糊精透析液相关的儿童超滤量的因素。
Pediatr Nephrol. 2023 Apr;38(4):1267-1273. doi: 10.1007/s00467-022-05720-0. Epub 2022 Sep 2.
2
Care of the pediatric patient on chronic peritoneal dialysis.儿科慢性腹膜透析患者的护理。
Pediatr Nephrol. 2022 Dec;37(12):3043-3055. doi: 10.1007/s00467-022-05605-2. Epub 2022 May 19.
3
Icodextrin and peritoneal dialysis: advantages and new applications.艾考糊精与腹膜透析:优势及新应用
Int Urol Nephrol. 2018 Mar;50(3):495-500. doi: 10.1007/s11255-017-1647-2. Epub 2017 Jul 3.
4
Impact of fill volume on ultrafiltration with icodextrin in children on chronic peritoneal dialysis.填充量对接受慢性腹膜透析的儿童使用艾考糊精进行超滤的影响。
Pediatr Nephrol. 2016 Oct;31(10):1673-9. doi: 10.1007/s00467-016-3398-1. Epub 2016 May 13.
5
Clinical effects of icodextrin in peritoneal dialysis.艾考糊精在腹膜透析中的临床疗效。
NDT Plus. 2008 Oct;1(Suppl 4):iv18-iv22. doi: 10.1093/ndtplus/sfn119.
6
Strategies for the preservation of residual renal function in pediatric dialysis patients.小儿透析患者残余肾功能的保护策略。
Pediatr Nephrol. 2014 May;29(5):825-36; quiz 832. doi: 10.1007/s00467-013-2554-0. Epub 2013 Jul 19.
7
Bimodal solutions or twice-daily icodextrin to enhance ultrafiltration in peritoneal dialysis patients.双峰溶液或每日两次使用艾考糊精以增强腹膜透析患者的超滤作用。
Int J Nephrol. 2013;2013:424915. doi: 10.1155/2013/424915. Epub 2013 Jan 8.
8
Peritoneal dialysis prescription in children: bedside principles for optimal practice.儿童腹膜透析处方:优化实践的床边原则
Pediatr Nephrol. 2009 Sep;24(9):1633-42; quiz 1640, 1642. doi: 10.1007/s00467-008-0979-7. Epub 2008 Sep 20.
9
Selection of modalities, prescription, and technical issues in children on peritoneal dialysis.儿童腹膜透析的方式选择、处方及技术问题
Pediatr Nephrol. 2009 Aug;24(8):1453-64. doi: 10.1007/s00467-008-0848-4. Epub 2008 Jun 3.
10
Pathogenesis and treatment of peritoneal membrane failure.腹膜衰竭的发病机制与治疗
Pediatr Nephrol. 2008 May;23(5):695-703. doi: 10.1007/s00467-007-0580-5. Epub 2007 Sep 21.